ArticleFrontiers in pharmacology2025

Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways.

Naif ALSuhaymi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.